Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 3:10 pm Sale | 2021-12-31 | 13G | REVOLUTION MEDICINES INC RVMD | Cormorant Asset Management, LP | 2,431,852 3.300% | -1,243,148 (-33.83%) | Filing History |
| 2022-02-14 3:09 pm Sale | 2021-12-31 | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | Cormorant Asset Management, LP | 17,266,144 7.060% | -138,558 (-0.80%) | Filing History |
| 2022-02-14 3:08 pm Sale | 2021-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Cormorant Asset Management, LP | 3,002,200 6.460% | -191,774 (-6.00%) | Filing History |
| 2022-02-14 3:08 pm Purchase | 2021-12-31 | 13G | CONSTELLATION PHARMACEUTICALS CNST | Cormorant Asset Management, LP | 5,440,451 9.770% | 325,607 (+6.37%) | Filing History |
| 2022-02-14 3:07 pm Sale | 2021-12-31 | 13G | BIOATLA INC BCAB | Cormorant Asset Management, LP | 40,764 5.770% | -5,077 (-11.08%) | Filing History |
| 2022-02-14 3:06 pm Sale | 2021-12-31 | 13G | AVIDITY BIOSCIENCES INC RNAM | Cormorant Asset Management, LP | 2,012,115 4.290% | -452,432 (-18.36%) | Filing History |
| 2022-02-14 3:05 pm Sale | 2021-12-31 | 13G | ATEA PHARMACEUTICALS INC AVIR | Cormorant Asset Management, LP | 1,679,442 2.020% | -4,731,913 (-73.81%) | Filing History |
| 2022-02-14 3:04 pm Purchase | 2021-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Cormorant Asset Management, LP | 1,436,322 6.280% | 977,178 (+212.83%) | Filing History |
| 2022-02-14 3:04 pm Sale | 2021-12-31 | 13G | OTONOMY INC OTIC | Cormorant Asset Management, LP | 0 0.000% | -2,600,000 (Position Closed) | Filing |
| 2022-02-14 3:03 pm Sale | 2021-12-31 | 13G | OMEROS CORPORATION OMER | Cormorant Asset Management, LP | 0 0.000% | -5,000,000 (Position Closed) | Filing History |
| 2022-02-14 3:02 pm Purchase | 2021-12-31 | 13G | TURNING PT THERAPEUTICS INC CO TPTX | Cormorant Asset Management, LP | 3,025,000 6.110% | 632,703 (+26.45%) | Filing History |
| 2022-02-14 3:01 pm Sale | 2021-12-31 | 13G | OLEMA PHARMACEUTICALS INC OLMA | Cormorant Asset Management, LP | 2,169,871 5.390% | -1,025,673 (-32.10%) | Filing History |
| 2022-02-14 3:01 pm Sale | 2021-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Cormorant Asset Management, LP | 1,403,331 6.790% | -310,938 (-18.14%) | Filing History |
| 2022-02-14 3:00 pm Purchase | 2021-12-31 | 13G | ELEDON PHARMACEUTICALS INC ELDN | Cormorant Asset Management, LP | 1,428,598 9.900% | 13,098 (+0.93%) | Filing History |
| 2021-08-13 4:01 pm Purchase | 2021-08-03 | 13G | IMMUNEERING CORP IMRX | Cormorant Asset Management, LP | 2,252,628 8.830% | 2,252,628 (New Position) | Filing History |
| 2021-08-10 4:01 pm Unchanged | 2021-07-26 | 13D | ERASCA INC ERAS | Cormorant Asset Management, LP | 10,505,553 8.830% | 0 (Unchanged) | Filing History |
| 2021-07-30 4:01 pm Purchase | 2021-07-20 | 13D | ERASCA INC ERAS | Cormorant Asset Management, LP | 10,505,553 8.830% | 10,505,553 (New Position) | Filing History |
| 2021-07-12 4:19 pm Purchase | 2021-07-02 | 13G | AEROVATE THERAPEUTICS INC AVTE | Cormorant Asset Management, LP | 58,020 8.320% | 58,020 (New Position) | Filing History |
| 2021-07-09 4:06 pm Purchase | 2021-06-29 | 13G | ELEVATION ONCOLOGY INC ELEV | Cormorant Asset Management, LP | 1,983,168 8.690% | 1,983,168 (New Position) | Filing History |
| 2021-07-08 4:02 pm Purchase | 2021-06-28 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Cormorant Asset Management, LP | 3,193,974 7.180% | 3,193,974 (New Position) | Filing History |